Delivery Order SPE2DX15D8002-SPE2DX24F2VB1
Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,857.60, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support the DLA Troop Support Medical's medical supply chain operations. The contract has a period of performance through May 30, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $2,440.92 and an ultimate completion date of March 21, 2025. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. also holds a significant single-award Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,909.62, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through January 24, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,230.88, is for the delivery of 4562802555 ELIQUIS 5 MG TABLET 60S to support military medical operations. Dakota Drug, Inc. holds a large Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,782.06, is for the delivery of ELIQUIS 5 MG TABLET 60S to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that allows the company to provide a comprehensive range of pharmaceutical products, medical...
- This is a Firm Fixed Price Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,624.29 contract is for the delivery of 4564885398 units of the pharmaceutical product ELIQUIS 5 MG TABLET 60S. The Delivery Order has a period of performance through June 13, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of ELIQUIS 5 MG TABLET 60S. The contract, with a ceiling value of $4,973.50 and a performance period extending through October 30, 2024, is a firm fixed-price delivery order. It is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,413.34, is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through February 13, 2025. Dakota Drug, Inc. also holds a larger indefinite delivery contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA...
- This is a firm fixed-price delivery order contract valued at $5,205.54, awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on June 21, 2024. Dakota Drug, Inc. is a key supplier for the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $13,602.16 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 27, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense....